It has been proposed that the greater therapeutic index of SSTC3 compared to other Wnt inhibitors is the result of the decreased abundance of CK1α protein in CRC tissue versus normal intestinal tissue (Figure 4C). This evidence concerns the gene CSNK1A1 and colorectal carcinoma.